Skip to main content

MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Oct 2026 Evaluate
The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90  millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 17250.70 12202.40 41.37 32137.40 24288.00 32.32 48459.20 43220.40 12.12
Other Income 526.20 750.30 -29.87 1234.40 1156.60 6.73 2044.00 1198.70 70.52
PBIDT 5697.10 3646.20 56.25 10372.30 7346.50 41.19 14023.90 13245.90 5.87
Interest 7.90 7.30 8.22 15.50 14.60 6.16 25.90 46.00 -43.70
PBDT 5689.20 3638.90 56.34 10356.80 7331.90 41.26 13998.00 13199.90 6.05
Depreciation 463.00 419.20 10.45 896.10 822.30 8.97 1687.70 1399.30 20.61
PBT 5226.20 3219.70 62.32 9460.70 6509.60 45.33 12310.30 11800.60 4.32
TAX 1427.30 724.40 97.03 2507.10 1464.60 71.18 2842.10 2631.70 7.99
Deferred Tax -158.10 64.70 -344.36 -94.60 97.60 -196.93 76.00 51.40 47.86
PAT 3798.90 2495.30 52.24 6953.60 5045.00 37.83 9468.20 9168.90 3.26
Equity 250.70 250.70 0.00 250.70 250.70 0.00 250.70 250.70 0.00
PBIDTM(%) 33.03 29.88 10.52 32.27 30.25 6.70 28.94 30.65 -5.57
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..